An Open-label Phase 1 Study to Evaluate Pharmacokinetic/Pharmacodynamic Drug-drug Interactions and Safety/Tolerability of DWC202211 and DWC202212 Compared to Coadministration in Healthy
Latest Information Update: 06 Apr 2023
At a glance
- Drugs DWC 202211 (Primary) ; DWC 202212 (Primary) ; Aspirin; Rabeprazole
- Indications Unspecified
- Focus Pharmacokinetics
- Sponsors Daewoong Pharmaceutical
Most Recent Events
- 03 Apr 2023 Status changed from not yet recruiting to recruiting.
- 03 Feb 2023 New trial record